Ozempic is in the next round of Medicare drug price negotiations. See the full list of 15 medications
The talks on drugs including Novo Nordisk's Wegovy, GSK's Trelegy Ellipta, and Pfizer's Xtandi will set Medicare prices that ...
Protagonist Therapeutics chief medical officer sells shares for tax obligations
Officer of Protagonist Therapeutics, Inc. (NASDAQ:PTGX), a $2.2 billion market cap biotech company, recently reported the sale of 3,640 shares of common stock on January 16, 2025. The transactions ...